VIR BIOTECHNOLOGY INC. - COMMON STOCK

Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2022 Financial Results

09 Aug 2022 13:02:00 By Nasdaq GlobeNewswire

Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2022 Financial Results on August 4, 2022

21 Jul 2022 13:05:00 By Nasdaq GlobeNewswire

Vir Biotechnology Announces Transition of Chief Scientific Officer

14 Jul 2022 05:30:00 By Nasdaq GlobeNewswire

Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program

25 Jun 2022 04:00:00 By Nasdaq GlobeNewswire

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Presentation at the International Liver Congress™ 2022

08 Jun 2022 04:33:58 By Nasdaq GlobeNewswire

Vir Biotechnology Reminds Stockholders of 2022 Annual General Meeting Details

18 May 2022 13:03:00 By Nasdaq GlobeNewswire

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results

05 May 2022 13:07:07 By Nasdaq GlobeNewswire

Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day

27 Apr 2022 05:39:21 By Nasdaq GlobeNewswire

Vir Biotechnology to Provide Corporate Update and Report First Quarter 2022 Financial Results on May 5, 2022

21 Apr 2022 13:05:00 By Nasdaq GlobeNewswire

Vir Biotechnology to Host a Virtual Hepatitis Portfolio R&D Day

13 Apr 2022 13:02:00 By Nasdaq GlobeNewswire

Vir Biotechnology Scientists Named Winners of the BARDA and HHS-Sponsored Pediatric COVID-19 Data Challenge

06 Apr 2022 09:14:06 By Nasdaq GlobeNewswire

Vir Biotechnology to Participate in the 21st Annual Needham Healthcare Conference

04 Apr 2022 13:02:00 By Nasdaq GlobeNewswire

US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant

25 Mar 2022 13:04:07 By Nasdaq GlobeNewswire

Vir Biotechnology to Participate in the 42nd Annual Cowen Healthcare Conference

02 Mar 2022 13:02:00 By Nasdaq GlobeNewswire

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

24 Feb 2022 13:04:06 By Nasdaq GlobeNewswire

Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

10 Feb 2022 13:02:00 By Nasdaq GlobeNewswire

Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2

09 Feb 2022 22:24:20 By Nasdaq GlobeNewswire

Vir Biotechnology Appoints Johanna Friedl-Naderer as Executive Vice President and Chief Business Officer, Global

08 Feb 2022 03:00:00 By Nasdaq GlobeNewswire

Vir Biotechnology Launches New Antibody Research Initiative Aimed at a Functional Cure for HIV and Prevention of Malaria

13 Jan 2022 06:05:16 By Nasdaq GlobeNewswire

GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19

13 Jan 2022 06:02:54 By Nasdaq GlobeNewswire